As mentioned, CML is characterized by the presence of the BCR-ABL1 oncogene (p210) in myeloid cells (as opposed to lymphoid cells in ALL) initiating the Chronic Phase of the disease. The gene discussed is EVPL; the disease is chronic myelogenous leukemia, BCR-ABL1 positive.